A judge blocked the FDA’s mandate that would require cigarette companies to publish a graphic warning on packaging; the Jynneos mpox vaccine effectively offered strong protection against the virus; intense movement was found to reduce the risk of death within 7 years.
A US district judge in Texas found that the FDA could not require that cigarette packages feature a graphic health warning, according to Reuters. The judge found that the requirement violated tobacco companies’ First Amendment rights by compelling speech. The FDA rule, which was first finalized in March 2020, would have required that all cigarette packaging contain images of the possible consequences of smoking, such as diseased feet, and had to occupy the top 50% of the front and back of all cigarette packages as well as the top 20% of all ads. The judge wrote that such images could cause consumers to take away misleading information.
The CDC published a study that found that people who received 1 or 2 doses of the Jynneos mpox vaccine contracted the virus at a significantly lower rate compared with unvaccinated individuals. According to STAT News, the study found that unvaccinated people were 9.6 times more likely to develop mpox compared with fully vaccinated people. Unvaccinated people had a higher incidence of infection at 7.6 times higher compared with people who had received 1 dose of the vaccine. The data was based on men aged 18 to 49 years who were diagnosed between July 31 and October 1, 2022.
Research published on Thursday found that short bursts of intense movement, such as climbing stairs, are associated with a lower risk of death in participants whose mean age was 62 years, according to NBC News. These intense daily activities could also include running for the bus or carrying heavy groceries, even if the person doesn’t exercise otherwise. Doing such activity for 1 to 2 minutes 3 to 4 times a day could reduce risk of death by 40% over 7 years, with the risk of heart disease reduced by 49% in the same span.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More